Chemical Evolution of Autotaxin Inhibitors

Overview

Journal Chem Rev

Publisher American Chemical Society

Specialty Chemistry

Date 2012 Feb 17

PMID 22335786

Citations 21

Authors

Harald M H G Albers

Huib Ovaa

Affiliations

Soon will be listed here.

Citing Articles

Design and Development of Autotaxin Inhibitors.

Jia Y, Li Y, Xu X, Tian Y, Shang H Pharmaceuticals (Basel). 2021; 14(11).

PMID: 34832985 PMC: 8622848. DOI: 10.3390/ph14111203.

Molecular modelling guided design, synthesis and QSAR analysis of new small molecule non-lipid autotaxin inhibitors.

Banerjee S, Norman D, Deng S, O Fakayode S, Lee S, Parrill A Bioorg Chem. 2020; 103:104188.

PMID: 32890995 PMC: 8163515. DOI: 10.1016/j.bioorg.2020.104188.

Oxidized Lipids in Persistent Pain States.

Osthues T, Sisignano M Front Pharmacol. 2019; 10:1147.

PMID: 31680947 PMC: 6803483. DOI: 10.3389/fphar.2019.01147.

Benzoxaboroles-Novel Autotaxin Inhibitors.

Kraljic K, Jelic D, Ziher D, Cvrtila A, Dragojevic S, Sinkovic V Molecules. 2019; 24(19).

PMID: 31547058 PMC: 6804080. DOI: 10.3390/molecules24193419.

Lysophosphatidic acid produced by autotaxin acts as an allosteric modulator of its catalytic efficiency.

Salgado-Polo F, Fish A, Matsoukas M, Heidebrecht T, Keune W, Perrakis A J Biol Chem. 2018; 293(37):14312-14327.

PMID: 30026231 PMC: 6139564. DOI: 10.1074/jbc.RA118.004450.

References

Kremer A, Martens J, Kulik W, Rueff F, Kuiper E, van Buuren H . Lysophosphatidic acid is a potential mediator of cholestatic pruritus. Gastroenterology. 2010; 139(3):1008-18, 1018.e1. DOI: 10.1053/j.gastro.2010.05.009. View

Gijsbers R, Aoki J, Arai H, Bollen M . The hydrolysis of lysophospholipids and nucleotides by autotaxin (NPP2) involves a single catalytic site. FEBS Lett. 2003; 538(1-3):60-4. DOI: 10.1016/s0014-5793(03)00133-9. View

Cui P, McCalmont W, Tomsig J, Lynch K, Macdonald T . alpha- and beta-substituted phosphonate analogs of LPA as autotaxin inhibitors. Bioorg Med Chem. 2007; 16(5):2212-25. PMC: 2907913. DOI: 10.1016/j.bmc.2007.11.078. View

Tokumura A, Miyake M, Yoshimoto O, Shimizu M, Fukuzawa K . Metal-ion stimulation and inhibition of lysophospholipase D which generates bioactive lysophosphatidic acid in rat plasma. Lipids. 1998; 33(10):1009-15. DOI: 10.1007/s11745-998-0299-2. View

Liu S, Umezu-Goto M, Murph M, Lu Y, Liu W, Zhang F . Expression of autotaxin and lysophosphatidic acid receptors increases mammary tumorigenesis, invasion, and metastases. Cancer Cell. 2009; 15(6):539-50. PMC: 4157573. DOI: 10.1016/j.ccr.2009.03.027. View

Kanda H, Newton R, Klein R, Morita Y, Gunn M, Rosen S . Autotaxin, an ectoenzyme that produces lysophosphatidic acid, promotes the entry of lymphocytes into secondary lymphoid organs. Nat Immunol. 2008; 9(4):415-23. PMC: 2783613. DOI: 10.1038/ni1573. View

Stracke M, Krutzsch H, Unsworth E, Arestad A, Cioce V, Schiffmann E . Identification, purification, and partial sequence analysis of autotaxin, a novel motility-stimulating protein. J Biol Chem. 1992; 267(4):2524-9. View

Albers H, van Meeteren L, Egan D, van Tilburg E, Moolenaar W, Ovaa H . Discovery and optimization of boronic acid based inhibitors of autotaxin. J Med Chem. 2010; 53(13):4958-67. DOI: 10.1021/jm1005012. View

Murph M, Tanaka T, Pang J, Felix E, Liu S, Trost R . Liquid chromatography mass spectrometry for quantifying plasma lysophospholipids: potential biomarkers for cancer diagnosis. Methods Enzymol. 2007; 433:1-25. DOI: 10.1016/S0076-6879(07)33001-2. View

10.

Gierse J, Thorarensen A, Beltey K, Bradshaw-Pierce E, Cortes-Burgos L, Hall T . A novel autotaxin inhibitor reduces lysophosphatidic acid levels in plasma and the site of inflammation. J Pharmacol Exp Ther. 2010; 334(1):310-7. DOI: 10.1124/jpet.110.165845. View

11.

Pamuklar Z, Federico L, Liu S, Umezu-Goto M, Dong A, Panchatcharam M . Autotaxin/lysopholipase D and lysophosphatidic acid regulate murine hemostasis and thrombosis. J Biol Chem. 2009; 284(11):7385-94. PMC: 2652269. DOI: 10.1074/jbc.M807820200. View

12.

Fogg A, Gray A, Burns D . Stability constants of metal complexes of bithionol, fenticlor and hexachlorophene. Anal Chim Acta. 1970; 51(2):265-70. DOI: 10.1016/S0003-2670(01)95715-0. View

13.

Postma F, Jalink K, Hengeveld T, Moolenaar W . Sphingosine-1-phosphate rapidly induces Rho-dependent neurite retraction: action through a specific cell surface receptor. EMBO J. 1996; 15(10):2388-92. PMC: 450169. View

14.

North E, Howard A, Wanjala I, Pham T, Baker D, Parrill A . Pharmacophore development and application toward the identification of novel, small-molecule autotaxin inhibitors. J Med Chem. 2010; 53(8):3095-105. DOI: 10.1021/jm901718z. View

15.

van Meeteren L, Ruurs P, Christodoulou E, Goding J, Takakusa H, Kikuchi K . Inhibition of autotaxin by lysophosphatidic acid and sphingosine 1-phosphate. J Biol Chem. 2005; 280(22):21155-61. DOI: 10.1074/jbc.M413183200. View

16.

Durgam G, Virag T, Walker M, Tsukahara R, Yasuda S, Liliom K . Synthesis, structure-activity relationships, and biological evaluation of fatty alcohol phosphates as lysophosphatidic acid receptor ligands, activators of PPARgamma, and inhibitors of autotaxin. J Med Chem. 2005; 48(15):4919-30. DOI: 10.1021/jm049609r. View

17.

Tanaka R, Kato M, Suzuki T, Nakazaki A, Nozaki E, Gotoh M . Efficient synthesis of 3-O-thia-cPA and preliminary analysis of its biological activity toward autotaxin. Bioorg Med Chem Lett. 2011; 21(14):4180-2. DOI: 10.1016/j.bmcl.2011.05.083. View

18.

Jansen S, Stefan C, Creemers J, Waelkens E, Van Eynde A, Stalmans W . Proteolytic maturation and activation of autotaxin (NPP2), a secreted metastasis-enhancing lysophospholipase D. J Cell Sci. 2005; 118(Pt 14):3081-9. DOI: 10.1242/jcs.02438. View

19.

Lin S, Wang D, Iyer S, Ghaleb A, Shim H, Yang V . The absence of LPA2 attenuates tumor formation in an experimental model of colitis-associated cancer. Gastroenterology. 2009; 136(5):1711-20. PMC: 2691721. DOI: 10.1053/j.gastro.2009.01.002. View

20.

Stefan C, Jansen S, Bollen M . Modulation of purinergic signaling by NPP-type ectophosphodiesterases. Purinergic Signal. 2008; 2(2):361-70. PMC: 2254485. DOI: 10.1007/s11302-005-5303-4. View